Zhejiang Hisun Pharmaceutical Co., Ltd. (SHA:600267)

China flag China · Delayed Price · Currency is CNY
10.46
+0.13 (1.26%)
Mar 10, 2026, 1:45 PM CST
23.06%
Market Cap 12.02B
Revenue (ttm) 9.84B
Net Income (ttm) 546.80M
Shares Out 1.16B
EPS (ttm) 0.47
PE Ratio 21.76
Forward PE 24.31
Dividend 0.21 (2.03%)
Ex-Dividend Date n/a
Volume 9,445,460
Average Volume 11,233,533
Open 10.38
Previous Close 10.33
Day's Range 10.33 - 10.51
52-Week Range 8.13 - 13.06
Beta 0.44
RSI 48.82
Earnings Date Apr 8, 2026

About SHA:600267

Zhejiang Hisun Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of biological and generic drugs in China. The company provides active pharmaceutical ingredients and finished dosage form products. It offers products for anti-tumor, anti-infection, cardiovascular, endocrine, immunosuppression, antidepressant, liver care, and orthopaedics treatment; and weight loss, anti-viral, anti-TB, animal healthcare, and others. The company also exports its products to approximately 70 countries worldwide. The company was fo... [Read more]

Sector Healthcare
Founded 1956
Employees 7,994
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 600267
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.